Relaxin-2 expression in temporal bone carcinoma-Reference-Cited by-同舟云学术

Relaxin-2 expression in temporal bone carcinoma

Published:2014-11-12 Issue:11 Volume:272 Page:3225-3232
ISSN:0937-4477
Container-title:European Archives of Oto-Rhino-Laryngology
language:en
Short-container-title:Eur Arch Otorhinolaryngol

Author:

Marioni Gino,Zanoletti Elisabetta,Lovato Andrea,Franchella Sebastiano,Giacomelli Luciano,Gianatti Andrea,Mazzoni Antonio,Blandamura Stella,Martini Alessandro

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Otorhinolaryngology

Link

http://link.springer.com/content/pdf/10.1007/s00405-014-3383-x.pdf

Reference20 articles.

1. Yin M, Ishikawa K, Honda K et al (2006) Analysis of 95 cases of squamous cell carcinoma of the external and middle ear. Auris Nasus Larynx 33:251–257

2. Lionello M, Stritoni P, Facciolo MC et al (2014) Temporal bone carcinoma. Current diagnostic, therapeutic, and prognostic concepts. J Surg Oncol 110:383–392

3. Zanoletti E, Marioni G, Stritoni P et al (2014) Temporal bone squamous cell carcinoma: analyzing prognosis with univariate and multivariate models. Laryngoscope 124:1192–1198

4. Cernaro V, Lacquaniti A, Lupica R et al (2014) Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein. Med Res Rev 34:77–105

5. Gedikli O, Yilmaz H, Kiris A et al (2009) Circulating levels of relaxin and its relation to cardiovascular function in patients with hypertension. Blood Press 18:68–73

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal Bone Squamous Cell Carcinoma: Molecular Markers Involved in Carcinogenesis, Behavior, and Prognosis: A Systematic Review;International Journal of Molecular Sciences;2022-04-20

2. Reply to Letter to the Editor regarding “Primary temporal bone squamous cell carcinoma: Comparing the prognostic value of the American Joint Committee on Cancer TNM classification (8th edition) with the revised Pittsburgh staging system”;Head & Neck;2022-04-05

3. Primary temporal bone squamous cell carcinoma: Comparing the prognostic value of the American Joint Committee on Cancer TNM classification (8th edition) with the revised Pittsburgh staging system;Head & Neck;2022-01-19

4. Tumor budding to investigate local invasion, metastasis and prognosis in temporal bone squamous cell carcinoma;Pathology - Research and Practice;2022-01

5. Reply to Letter to the Editor regarding “Temporal bone carcinoma: Novel prognostic score based on clinical and histological features”;Head & Neck;2021-02-18